반응식
Br[CH2:2][C:3]([C:5]1[CH:13]=[CH:12][C:8]2[O:9][CH2:10][O:11][C:7]=2[CH:6]=1)=[O:4].[Cl:14][C:15]1[CH:23]=[C:22]2[C:18]([C:19]([CH2:36][C:37]([O:39][CH3:40])=[O:38])=C(C(C3N=CC4CCCCC=4C=3)=O)[NH:21]2)=[CH:17][CH:16]=1>>[O:9]1[C:8]2[CH:12]=[CH:13][C:5]([C:3]([C:2]3[NH:21][C:22]4[C:18]([C:19]=3[CH2:36][C:37]([O:39][CH3:40])=[O:38])=[CH:17][CH:16]=[C:15]([Cl:14])[CH:23]=4)=[O:4])=[CH:6][C:7]=2[O:11][CH2:10]1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 2 of Example 1 from 5-bromoacetyl-1,3-benzodioxole (J.Med. Chem., 1977, 20, 394) and methyl trans-4-chloro-2-[(phenylsulfonyl)amino]cinnamate (Example 1, step 1).
출처 및 근거
- ORD 기록
- ord-ae9addeab3914caabee7f48187873a82
- 출처 데이터셋
- uspto-grants-2001_10
- 특허 번호
- US06303628B1
연결된 노트
불러오는 중…